Fidson Healthcare Plc (NGX:FIDSON)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
40.00
0.00 (0.00%)
At close: Nov 18, 2025
Market Cap91.80B
Revenue (ttm)117.54B
Net Income (ttm)10.31B
Shares Out2.29B
EPS (ttm)4.49
PE Ratio8.91
Forward PEn/a
Dividend1.00 (2.50%)
Ex-Dividend DateJul 14, 2025
Volume193,423
Average Volume484,817
Openn/a
Previous Close40.00
Day's Rangen/a
52-Week Range13.84 - 47.00
Beta0.51
RSI22.39
Earnings DateOct 30, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 674
Stock Exchange Nigerian Stock Exchange
Ticker Symbol FIDSON
Full Company Profile

Financial Performance

In 2024, Fidson Healthcare's revenue was 84.19 billion, an increase of 58.70% compared to the previous year's 53.05 billion. Earnings were 5.78 billion, an increase of 60.20%.

Financial Statements

News

There is no news available yet.